Post-operative urothelial recurrence in patients with upper urinary tract urothelial carcinoma managed by radical nephroureterectomy with an ipsilateral bladder cuff: Minimal prognostic impact in comparison with non-urothelial recurrence and other clinical indicators
Tóm tắt
Từ khóa
Tài liệu tham khảo
Margulis, 2010, Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract, J Urol, 184, 453, 10.1016/j.juro.2010.03.142
Oosterlinck, 2004, EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma, Eur Urol, 46, 147, 10.1016/j.eururo.2004.04.011
Raman, 2007, Management of patients with upper urinary tract transitional cell carcinoma, Nat Clin Pract Urol, 4, 432, 10.1038/ncpuro0875
Hall, 1998, Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients, Urology, 52, 594, 10.1016/S0090-4295(98)00295-7
Langner, 2006, pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract, Mod Pathol, 19, 272, 10.1038/modpathol.3800529
Novara, 2007, Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers, Cancer, 110, 1715, 10.1002/cncr.22970
Secin, 2007, Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer, Int J Urol, 14, 26, 10.1111/j.1442-2042.2006.01664.x
Brown, 2006, Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?, BJU Int, 98, 1176, 10.1111/j.1464-410X.2006.06524.x
Waldert, 2010, A delay in radical nephroureterectomy can lead to upstaging, BJU Int, 105, 812, 10.1111/j.1464-410X.2009.08821.x
Zigeuner, 2010, Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract, Eur Urol, 57, 575, 10.1016/j.eururo.2009.11.035
Margulis, 2009, Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration, Cancer, 115, 1224, 10.1002/cncr.24135
Epstein, 1998, The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee, Am J Surg Pathol, 22, 1435, 10.1097/00000478-199812000-00001
Eng, 2008, Laparoscopic nephroureterectomy: long-term outcomes, Curr Opin Urol, 18, 157, 10.1097/MOU.0b013e3282f4a9ca
Kikuchi, 2009, Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma, J Clin Oncol, 27, 612, 10.1200/JCO.2008.17.2361
Remzi, 2009, Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients, BJU Int, 103, 307, 10.1111/j.1464-410X.2008.08003.x
Otto, 2011, Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients, World J Urol, 29, 487, 10.1007/s00345-011-0645-8
Koda, 2007, Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery, Jpn J Clin Oncol, 37, 296, 10.1093/jjco/hym016
Kusuda, 2011, Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy, Urol Oncol
Terakawa, 2008, Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract, Urology, 71, 123, 10.1016/j.urology.2007.08.054
Pieras, 2010, Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma, BJU Int, 106, 1319, 10.1111/j.1464-410X.2010.09341.x
Wu, 2010, Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?, J Urol, 183, 56, 10.1016/j.juro.2009.08.154
Novara, 2009, Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers, Int J Urol, 16, 187, 10.1111/j.1442-2042.2008.02201.x
Youssef, 2011, Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma, Urology, 77, 861, 10.1016/j.urology.2010.09.032
Remzi, 2011, Upper urinary tract urothelial carcinoma: what have we learned in the last 4 years?, Ther Adv Urol, 3, 69, 10.1177/1756287211403349
Lehmann, 2009, Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05), Eur Urol, 55, 1293, 10.1016/j.eururo.2008.11.039
Bolenz, 2009, Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density, BJU Int, 103, 302, 10.1111/j.1464-410X.2008.07988.x
Abe, 2010, Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes, Eur J Surg Oncol, 36, 1085, 10.1016/j.ejso.2010.08.134
Lughezzani, 2010, A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma, Urology, 75, 118, 10.1016/j.urology.2009.07.1296